Wealthspring Capital’s Aimei Health Technology Co AFJK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-479,050
Closed -$5.02M 87
2024
Q3
$5.02M Sell
479,050
-55,060
-10% -$574K 6.19% 2
2024
Q2
$5.53M Sell
534,110
-2,390
-0.4% -$24.6K 6.43% 2
2024
Q1
$5.48M Buy
+536,500
New +$5.46M 6.48% 4

Other funds holding AFJK

Wealthspring Capital's AFJK Position: Q4 2024 in Review

Wealthspring Capital sold out of Aimei Health Technology Co (AFJK) in Q4 2024, closing a stake of 479,050 shares — an estimated $5.02M sold.

Wealthspring Capital first reported a position in AFJK in Q1 2024 and held it in 3 quarters. The position peaked at $5.53M in Q2 2024. 23 funds tracked by Wall St. Rank hold AFJK as of Q4 2024.

  • Wealthspring Capital reported no remaining Aimei Health Technology Co position as of Q4 2024 after selling out during the quarter.
  • Wealthspring Capital sold 479,050 Aimei Health Technology Co shares in Q4 2024, an estimated $5.02M.
  • Wealthspring Capital first reported a position in Aimei Health Technology Co in Q1 2024 and held it in 3 quarters.
  • Wealthspring Capital's Aimei Health Technology Co position peaked at $5.53M in Q2 2024.
  • 23 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q4 2024.

Based on Wealthspring Capital's 13F filing for Q4 2024, filed 5 Feb 2025.